THC

Study: Following Cannabis Commercialization, Occasional Use in Those With Psychosis History Increased Much More Than in General Population, Posing Potential Risk
What impact has legalization and commercialization of recreational cannabis had on people with schizophrenia and other disorders involving psychosis? It’s an important question, particularly in view… Read More
Low Levels of Cannabinoid Receptor in New Psychosis Patients Suggest a Possible Drug Target
Since the 1980s scientists have known that the body contains numerous cellular receptors that interact with naturally generated molecules that are chemically related to THC, the substance which gives… Read More
Study Suggests Cannabis Can Make Schizophrenia Medication Less Effective
New research in mice reveals how THC, the main psychoactive compound in cannabis, can reduce the effectiveness of risperidone, an antipsychotic drug used widely to treat people with schizophrenia.… Read More